![Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis - ScienceDirect Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1198743X17301271-gr1.jpg)
Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis - ScienceDirect
![Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02134-16/asset/429104bc-c04a-4475-a496-84abcfb918c8/assets/graphic/zac00317-5971-t01.jpeg)
Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy
![Hemodialysis for treatment of levofloxacin‐induced neurotoxicity - Idrees - 2019 - Hemodialysis International - Wiley Online Library Hemodialysis for treatment of levofloxacin‐induced neurotoxicity - Idrees - 2019 - Hemodialysis International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/20f66e15-94f7-4b56-9642-48a1eae688a4/hdi12687-fig-0001-m.jpg)
Hemodialysis for treatment of levofloxacin‐induced neurotoxicity - Idrees - 2019 - Hemodialysis International - Wiley Online Library
![Pharmacokinetics of Moxifloxacin and Levofloxacin in Intensive Care Unit Patients Who Have Acute Renal Failure and Undergo Extended Daily Dialysis | American Society of Nephrology Pharmacokinetics of Moxifloxacin and Levofloxacin in Intensive Care Unit Patients Who Have Acute Renal Failure and Undergo Extended Daily Dialysis | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/1/6/1263/F2.large.jpg)
Pharmacokinetics of Moxifloxacin and Levofloxacin in Intensive Care Unit Patients Who Have Acute Renal Failure and Undergo Extended Daily Dialysis | American Society of Nephrology
Full article: Levofloxacin-Induced Delirium: Is It a Dangerous Drug in Patients with Renal Dysfunction?
![Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02134-16/asset/0e5c4047-f698-4020-a4df-e3747238db09/assets/graphic/zac0031759710002.jpeg)
Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy
![Pharmacokinetics of Moxifloxacin and Levofloxacin in Intensive Care Unit Patients Who Have Acute Renal Failure and Undergo Extended Daily Dialysis | American Society of Nephrology Pharmacokinetics of Moxifloxacin and Levofloxacin in Intensive Care Unit Patients Who Have Acute Renal Failure and Undergo Extended Daily Dialysis | American Society of Nephrology](https://cjasn.asnjournals.org/content/1/6/1263/F1.large.jpg)
Pharmacokinetics of Moxifloxacin and Levofloxacin in Intensive Care Unit Patients Who Have Acute Renal Failure and Undergo Extended Daily Dialysis | American Society of Nephrology
![Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet Oncology Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/asset/046c525d-65cd-4490-8082-4091bd898c6f/gr1.jpg)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet Oncology
![Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02134-16/asset/ab388cc3-fbee-4633-baa4-6b4f001579d6/assets/graphic/zac0031759710001.jpeg)
Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function | Antimicrobial Agents and Chemotherapy
![A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use - Phylicia Baird, Sam Leung, Huy Hoang, Olawumi Babalola, Craig E Devoe, Rimda Wanchoo, Kenar D Jhaveri, A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use - Phylicia Baird, Sam Leung, Huy Hoang, Olawumi Babalola, Craig E Devoe, Rimda Wanchoo, Kenar D Jhaveri,](https://journals.sagepub.com/cms/10.1177/1078155214568581/asset/images/large/10.1177_1078155214568581-fig1.jpeg)
A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use - Phylicia Baird, Sam Leung, Huy Hoang, Olawumi Babalola, Craig E Devoe, Rimda Wanchoo, Kenar D Jhaveri,
![Frontiers | Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis Frontiers | Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis](https://www.frontiersin.org/files/Articles/658095/fphar-12-658095-HTML/image_m/fphar-12-658095-g001.jpg)